JCX-8-23 (May 09, 2023)
Present Law And Economic Background Relating To Pharmaceutical Manufacturers And U.S. International Tax Policy
The Senate Committee on Finance has scheduled a public hearing on May 11, 2023, titled “Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy.” The staff of the Joint Committee on Taxation has prepared a document that describes legal and economic background on U.S. taxation of U.S. multinational corporations and their cross-border activities.
The Senate Committee on Finance has scheduled a public hearing on May 11, 2023, titled “Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy.” The staff of the Joint Committee on Taxation has prepared a document that describes legal and economic background on U.S. taxation of U.S. multinational corporations and their cross-border activities.
Related Publications
-
JCX-29-23 (June 09, 2023)
Estimated Revenue Effects Of H.R. 3938, The “Build It In America Act” Scheduled For Markup By The Committee On Ways And Means On June 13, 2023
view details -
JCX-28-23 (June 09, 2023)
Description of H.R. 3938, The “Build It In America Act”
view details -
JCX-27-23 (June 09, 2023)
Estimated Revenue Effects Of H.R. 3937, The “Small Business Jobs Act” Scheduled For Markup By The Committee On Ways And Means On June 13, 2023
view details